Back to School: How biopharma can reboot drug development. Access exclusive analysis here
The university launched not-for-profit translational research company Drug Innovation Ventures at Emory LLC (DRIVE)
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury